LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $854,693 | -69.2% | 784,122 | -35.4% | 0.00% | -66.7% |
| Q2 2023 | $2,779,433 | -61.1% | 1,213,726 | -58.7% | 0.00% | -62.5% |
| Q1 2023 | $7,146,623 | +21.6% | 2,940,997 | -4.5% | 0.01% | +33.3% |
| Q4 2022 | $5,878,928 | -19.5% | 3,077,973 | +1.1% | 0.01% | -33.3% |
| Q3 2022 | $7,306,000 | +21.7% | 3,043,977 | -5.7% | 0.01% | +28.6% |
| Q2 2022 | $6,004,000 | -11.0% | 3,228,072 | -0.0% | 0.01% | +16.7% |
| Q1 2022 | $6,748,000 | -39.0% | 3,228,704 | +15.0% | 0.01% | -33.3% |
| Q4 2021 | $11,066,000 | -28.5% | 2,808,428 | -12.7% | 0.01% | -35.7% |
| Q3 2021 | $15,470,000 | -0.9% | 3,216,048 | -5.5% | 0.01% | +7.7% |
| Q2 2021 | $15,617,000 | -11.5% | 3,402,425 | +13.2% | 0.01% | -23.5% |
| Q1 2021 | $17,649,000 | +187.6% | 3,006,612 | +67.6% | 0.02% | +240.0% |
| Q4 2020 | $6,136,000 | +340.8% | 1,794,009 | +85.6% | 0.01% | +400.0% |
| Q3 2020 | $1,392,000 | -47.1% | 966,607 | -26.7% | 0.00% | -66.7% |
| Q2 2020 | $2,632,000 | +163.5% | 1,319,151 | +157.4% | 0.00% | +50.0% |
| Q1 2020 | $999,000 | +47.8% | 512,412 | +214.4% | 0.00% | +100.0% |
| Q4 2019 | $676,000 | +1308.3% | 162,971 | +927.4% | 0.00% | – |
| Q3 2019 | $48,000 | -88.3% | 15,862 | -75.8% | 0.00% | -100.0% |
| Q2 2019 | $411,000 | -68.7% | 65,437 | -72.3% | 0.00% | -50.0% |
| Q1 2019 | $1,313,000 | -26.4% | 236,121 | -12.1% | 0.00% | 0.0% |
| Q4 2018 | $1,783,000 | +75.1% | 268,476 | +181.5% | 0.00% | +100.0% |
| Q3 2018 | $1,018,000 | +9.2% | 95,380 | +22.9% | 0.00% | 0.0% |
| Q2 2018 | $932,000 | +137.2% | 77,636 | +69.2% | 0.00% | 0.0% |
| Q1 2018 | $393,000 | +13.9% | 45,895 | +31.6% | 0.00% | – |
| Q4 2017 | $345,000 | -11.3% | 34,878 | +10.3% | 0.00% | -100.0% |
| Q3 2017 | $389,000 | -79.5% | 31,621 | -72.6% | 0.00% | -66.7% |
| Q2 2017 | $1,896,000 | -21.5% | 115,256 | -31.6% | 0.00% | -25.0% |
| Q1 2017 | $2,416,000 | +98.7% | 168,494 | +91.6% | 0.00% | +100.0% |
| Q4 2016 | $1,216,000 | -89.9% | 87,952 | -86.8% | 0.00% | -90.5% |
| Q3 2016 | $12,055,000 | +325.8% | 667,130 | +238.1% | 0.02% | +320.0% |
| Q2 2016 | $2,831,000 | +181.1% | 197,303 | +134.0% | 0.01% | +150.0% |
| Q1 2016 | $1,007,000 | +291.8% | 84,300 | +336.6% | 0.00% | – |
| Q4 2015 | $257,000 | +8.0% | 19,309 | -13.0% | 0.00% | – |
| Q3 2015 | $238,000 | – | 22,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |